Home β€Ί Healthcare β€Ί Biotechnology β€Ί Global Human Microbiome Market

Global Human Microbiome Market Size, Share, Opportunities, And Trends By Product (Probiotics, Prebiotics, Supplements, Others), By Disease (Diabetes, Autoimmune Disorders, Cancer, Obesity, Others), By Application (Diagnostics, Therapeutics), And By Geography – Forecasts From 2025 To 2030

πŸ“₯ Download Free SampleπŸ’¬ Speak to Analyst
$3,950
Single User License
Access Full Insights
Report OverviewSegmentationTable of ContentsCustomize Report

Report Overview

🎯

Global Human Microbiome Market Highlights

North America (US, Canada and Mexico)
South America (Brazil, Argentina, and Others)
Europe (Germany, France, United Kingdom, Spain, Italy and Others
Middle East and Africa (Saudi Arabia, UAE and Others)
Asia Pacific (China, India, Japan, South Korea, Thailand and Others)

Human Microbiome Market Size:

The human microbiome market will grow at a CAGR of 20.42% to reach US$2,383.317 million in 2030 from US$941.215 million in 2025.

Major factors driving the global human microbiome market growth are increasing instances of lifestyle diseases, diarrheal infections, predominant changes in the lifestyle of the global population, and an increase in the aged population and its applications in healthcare. Moreover, technological enhancements in biomedical sciences and growing research investment in technology and product sectors is also positively impacting the market growth positively. However, lack of awareness about the use and advantages of prebiotics and probiotics and government restrictions on their usage are major challenges for the market players.

The global human microbiome market report provides a detailed analysis of the industry landscape, offering strategic and executive-level insights supported by data-driven forecasts and analysis. This regularly updated report equips decision-makers with actionable intelligence on current market trends, emerging opportunities, and competitive dynamics. It explores consumer demand across various regions and product types, such as therapeutics, diagnostics, and probiotics, while also examining purchasing behaviours and key customer segments. Additionally, the report delves into technological advancements, key government policies, regulation.

Global Human Microbiome Market Segmentations:

Global Human Microbiome Market Segmentation by product:

The market analyzed by product into the following:

  • Probiotic
  • Prebiotics
  • Supplements
  • Others

Global Human Microbiome Market Segmentation by disease:

The market analyzed by disease into the following:

  • Diabetes
  • Autoimmune Disorder
  • Cancer
  • Obesity
  • Others

Global Human Microbiome Market Segmentation by application:

The market analyzed by application into the following:

  • Diagnostics
  • Therapeutics

Global Human Microbiome Market Segmentation by regions:

The study also analysed the global human microbiome market into the following regions, with country level forecasts and analysis as below:

Global Human Microbiome Market Competitive Landscape:

The global human microbiome market features key players such as Seres Therapeutics, Microbiome Therapeutics Innovation Group, Vedanta Biosciences Inc., Metabiomics, Ferring Pharmaceuticals, Finch Therapeutics, BiomeBank, Biohm Technologies, Resbiotic, Immuron Limited, Maat Pharma among others.

Global Human Microbiome Market Report Coverage:

This report provides extensive coverage as explained in the points below:

  • Human Microbiome Market size, forecasts, and trends by product, with historical revenue data and analysis focusing on key factors driving adoption, current challenges faced by key players, and major growth areas.
  • Human Microbiome Market size, forecasts, and trends by disease, with historical revenue data and analysis.
  • Human Microbiome Market size, forecasts, and trends by application, with historical revenue data and analysis.
  • The Human Microbiome Market is also analysed across different regions, with historical data, regional share, attractiveness and opportunity of these solutions in different countries. The growth prospects and key players operating in these markets. The section also dwells on the macro factors, economic scenario and other complementing factors aiding in market growth. 
  • Market dynamics: The section details the market growth factors, restraints, and opportunities in the market. The segment also presents complete market scenario with the help of Porter’s five forces model. 
  • Competitive Intelligence: A thorough investigation on the competitive structure of the market presented through proprietary vendor matrix model, market share analysis of key players, insights on strategies of key players and recent major developments undertaken by the companies to gain competitive edge. 
  • Research methodology: The assumptions and sources which were considered to arrive at the final market estimates. Additionally, how our model is refined to ensure most significant factors are taken into consideration with the proper hypothesis and bottom-up and top-down approaches enhance the reliability of forecasts further strengthening the trustworthiness of the numbers being presented. 

How this report is helpful to you and reasons for purchase?

  • The report provides a strategic outlook of the human microbiome market to the decision-makers, analysts and other stakeholders in the easy to read format for taking informed decisions.
  • The charts, tables and figures make it easy for the executives to gain valuable insights while skimming the report. 
  • Analyst support through calls and email for timely clarification and incorporating additional requests. 
  • Option of presentation or doc format with the estimates file to take care of diverse requirements. 
  • 15% FREE customization with all our reports help cater additional requirements with significant cost-savings. 
  • Option of purchasing specific segments of the study, including opting for summary reports or just the estimates file. 

Human Microbiome Market Scope:

Report Metric Details
Study Period 2021 to 2031
Historical Data 2021 to 2024
Base Year 2025
Forecast Period 2026 – 2031
Report Metric Details
Human Microbiome Market Size in 2025 US$941.215 million
Human Microbiome Market Size in 2030 US$2,383.317 million
Growth Rate CAGR of 20.42%
Study Period 2020 to 2030
Historical Data 2020 to 2023
Base Year 2024
Forecast Period 2025 – 2030
Forecast Unit (Value) USD Million
Segmentation
  • Product
  • Disease
  • Application
  • Geography
Geographical Segmentation North America, South America, Europe, Middle East and Africa, Asia Pacific
List of Major Companies in the Human Microbiome Market
  • Seres Therapeutics
  • Microbiome Therapeutics Innovation Group
  • Vedanta Biosciences Inc.
  • Metabiomics
  • Ferring Pharmaceuticals
Customization Scope Free report customization with purchase

 

Our Best-Performing Industry Reports:

REPORT DETAILS

Report ID:KSI061610813
Published:Mar 2025
Pages:148
Format:PDF, Excel, PPT, Dashboard
πŸ“₯ Download SampleπŸ“ž Speak to AnalystπŸ“§ Request Customization

Need Assistance?

Our research team is available to answer your questions.

Contact Us

Frequently Asked Questions

The human microbiome market is expected to reach a total market size of US$2,383.317 million by 2030.

Human Microbiome Market is valued at US$941.215 million in 2025.

The human microbiome market is expected to grow at a CAGR of 20.42% during the forecast period.

Key drivers include rising gut health awareness, microbiome-based therapies, personalized medicine, and increasing research investments.

The North American region is anticipated to hold a significant share of the human microbiome market.

Related Reports

Healthcare

Pre-Clinical CRO Market Size, Share, Opportunities, and Trends By Service Type (Toxicology Testing, Pharmacokinetics & Pharmacodynamics, Safety Pharmacology, Bioanalytical Services, In Vitro Testing, In Vivo Models), By Drug Type (Biologics, Vaccines, Small Molecules, Cell/Gene Therapies), By Therapeutic Area (Oncology, CNS Disorders, Infectious Diseases, Cardiovascular Diseases, Metabolic Disorders, Rare Diseases, Others), By End-User (Biotech Startups, Large Pharma, Medical Device Companies, Academic/Government Institutes), And By Geography – Forecasts From 2025 To 2030

May 2025
Healthcare

Clinical CRO Market Size, Share, Opportunities, And Trends By Clinical Phase (Phase I Trials, Phase II Trials, Phase III Trials, Phase IV [Post-Marketing Surveillance]), By Therapeutic Area (Oncology, CNS, Cardiovascular, Infectious Diseases, Immunology, Metabolic Disorders, Rare Diseases, Others), By Service Category (Clinical Operations And Monitoring, Data And Analytics, Regulatory And Safety, Real-World Evidence [RWE] & Health Economics Outcomes Research [HEOR]), By Client Type (Large Pharma, Small & Mid Biotech, Medical Device Companies, Government And Academic Institutes, CDMOs), And By Geography – Forecasts From 2025 To 2030

May 2025
Healthcare

Industrial Biotechnology Market Size, Share, Opportunities, And Trends By Technology (Fermentation, Genetic Engineering, Others), By Raw Materials (Enzymes, Microorganisms, Bacteria, Yeast, Others), By Application (Biofuel, Biopolymer, Biochemicals, Biomedicines, Others), By End-User (Pharmaceutical, Food & Beverage, Chemical, Energy & Power, Textiles, Others), And By Geography – Forecasts From 2025 To 2030

May 2025
Healthcare

Botulinum Toxins Market - Strategic Insights and Forecasts (2025-2030)

Jan 2026
View All Reports